Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the severity of sepsis, along with the dearth of upcoming competition and lack of safe and effective therapies targeting the systemic inflammatory response, makes this indication commercially attractive. According to the report entitled Sepsis -- Search for a Safe Drug Targeting the Inflammatory/Coagulation Cascade, given the drawbacks of Lilly's Xigris (significant side effects, contraindications), novel agents that can target the inflammatory/coagulation cascade and offer a safer profile are needed.
The report also finds that there is significant risk associated with entering the market.
"The complex nature of sepsis pathophysiology and the heterogeneous population make clinical development in sepsis a risky undertaking for biopharmaceutical manufacturers," says John Lebbos, M.D., analyst at Decision Resources. "Indeed, several highly promising approaches (anti-tumor necrosis factor, antithrombin III, antiplatelet activating factor, tissue factor pathway inhibitor) have failed in clinical trials."
About Sepsis -- Search for a Safe Drug Targeting the Inflammatory/Coagulation Cascade
Sepsis -- Search for a Safe Drug Targeting the Inflammatory/Coagulation Cascade covers the current state of the sepsis drug market. The report includes the following:
* Analysis of the sepsis market focused on the diagnosed/drug-treated populations, patient/market share projections, cost per day, and compliance expectations. * High prescribing physicians identify the specific clinical trial end points that most impact prescribing and project the patient share such an advance would capture. * A ten-year forecast that builds on drug development advances and physician acceptance balanced by payer constraints and generic introductions.
The report can be purchased by contacting Decision Resources. Members of the media may request a complimentary copy.
About Decision Resources
Decision Resources, Inc., (http://www.decisionresources.com/) is a world leader in market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact: Elizabeth Marshall Decision Resources, Inc. 781-296-2563 email@example.com
SOURCE: Decision Resources, Inc.
CONTACT: Elizabeth Marshall of Decision Resources, Inc., +1-781-296-2563,
Web site: http://www.decisionresources.com/